Astrocytes are fundamental components of brain information processing and possess the ability to respond to synaptic signaling with increases in cytoplasmic calcium and modulate neuronal activity with the subsequent release of neuroactive transmitters. Dopamine signaling is essential for brain physiology and pathology, participating in learning and memory, motor control, neurological diseases, and psychiatric diseases, and astrocytes are emerging as a key cellular target of dopamine signaling. The present review will examine evidence revealing that astrocytes respond to dopamine and modulate information processing in the primary brain regions implicated in the mesolimbic dopamine system. Astrocytes exhibit circuit-specific modulation of neuronal networks and have the potential to serve as a therapeutic target for interventions designed for dopamine pathologies.
Subscribe to Journal
Get full journal access for 1 year
only $9.15 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Bushong EA, et al. Protoplasmic astrocytes in CA1 stratum radiatum occupy separate anatomical domains. J Neurosci. 2002;22:183–92.
Perea G, Navarrete M, Araque A. Tripartite synapses: astrocytes process and control synaptic information. Trends Neurosci. 2009;32:421–31.
Vasile F, Dossi E, Rouach N. Human astrocytes: structure and functions in the healthy brain. Brain Struct Funct. 2017;222:2017–29.
Allen NJ, Lyons DA. Glia as architects of central nervous system formation and function. Science. 2018;362:181–5.
Araque A, et al. Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci. 1999;22:208–15.
Khakh BS, Deneen B. The emerging nature of astrocyte diversity. Annu Rev Neurosci. 2019;42:187–207.
Allen NJ, Eroglu C. Cell biology of astrocyte-synapse interactions. Neuron. 2017;96:697–708.
Bezzi P, Volterra A. A neuron-glia signalling network in the active brain. Curr Opin Neurobiol. 2001;11:387–94.
Araque A, et al. Gliotransmitters travel in time and space. Neuron. 2014;81:728–39.
Bazargani N, Attwell D. Astrocyte calcium signaling: the third wave. Nat Neurosci. 2016;19:182–9.
Verkhratsky A, Orkand RK, Kettenmann H. Glial calcium: homeostasis and signaling function. Physiol Rev. 1998;78:99–141.
Huck JH, et al. De novo expression of dopamine D2 receptors on microglia after stroke. J Cereb Blood Flow Metab. 2015;35:1804–11.
Färber K, Pannasch U, Kettenmann H. Dopamine and noradrenaline control distinct functions in rodent microglial cells. Mol Cell Neurosci. 2005;29:128–38.
Bongarzone ER, et al. Identification of the dopamine D3 receptor in oligodendrocyte precursors: potential role in regulating differentiation and myelin formation. J Neurosci. 1998;18:5344–53.
Rosin C, et al. Dopamine D2 and D3 receptor agonists limit oligodendrocyte injury caused by glutamate oxidative stress and oxygen/glucose deprivation. Glia. 2005;52:336–43.
Missale C, et al. Dopamine receptors: from structure to function. Physiological Rev. 1998;78:189–225.
Pierce RC, Kumaresan V. The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse? Neurosci Biobehav Rev. 2006;30:215–38.
Nestler EJ, Carlezon WA Jr. The mesolimbic dopamine reward circuit in depression. Biol Psychiatry. 2006;59:1151–9.
Wightman RM, Robinson DL. Transient changes in mesolimbic dopamine and their association with ‘reward’. J Neurochem. 2002;82:721–35.
Beaulieu JM, Gainetdinov RR. The physiology, signaling, and pharmacology of dopamine receptors. Pharm Rev. 2011;63:182–217.
Morales M, Margolis EB. Ventral tegmental area: cellular heterogeneity, connectivity and behaviour. Nat Rev Neurosci. 2017;18:73.
Zanassi P, et al. Pharmacological and molecular evidence for dopamine D(1) receptor expression by striatal astrocytes in culture. J Neurosci Res. 1999;58:544–52.
Nagatomo K, et al. Dopamine D1 receptor immunoreactivity on fine processes of GFAP-positive astrocytes in the substantia nigra pars reticulata of adult mouse. Front Neuroanat. 2017;11:3.
Reuss B, et al. Regionally distinct regulation of astroglial neurotransmitter receptors by fibroblast growth factor-2. Mol Cell Neurosci. 2000;16:42–58.
Miyazaki I, et al. Direct evidence for expression of dopamine receptors in astrocytes from basal ganglia. Brain Res. 2004;1029:120–3.
Corkrum M, et al. Dopamine-evoked synaptic regulation in the nucleus accumbens requires astrocyte activity. Neuron. 2020;105:1036–47. e5
Shibasaki K, et al. Glycine release from astrocytes via functional reversal of GlyT1. J Neurochem. 2017;140:395–403.
Bal A, et al. Evidence for dopamine D2 receptor mRNA expression by striatal astrocytes in culture: in situ hybridization and polymerase chain reaction studies. Brain Res Mol Brain Res. 1994;23:204–12.
Qiu J, et al. Sinomenine activates astrocytic dopamine D2 receptors and alleviates neuroinflammatory injury via the CRYAB/STAT3 pathway after ischemic stroke in mice. J Neuroinflammation. 2016;13:263.
Montoya A, et al. Dopamine receptor D3 signalling in astrocytes promotes neuroinflammation. J Neuroinflammation. 2019;16:1–19.
Elgueta D, et al. Pharmacologic antagonism of dopamine receptor D3 attenuates neurodegeneration and motor impairment in a mouse model of Parkinson’s disease. Neuropharmacology. 2017;113:110–23.
Kumar U, Patel SC. Immunohistochemical localization of dopamine receptor subtypes (D1R-D5R) in Alzheimer’s disease brain. Brain Res. 2007;1131:187–96.
Svingos AL, Periasamy S, Pickel VM. Dopamine D4 receptors are strategically localized for primary involvement in the presynaptic effects of dopamine in the rat nucleus accumbens shell. Ann N Y Acad Sci. 1999;877:679–83.
Hansson E, Rönnbäck L, Sellström Å. Is there a “dopaminergic glial cell”? Neurochem Res. 1984;9:679–89.
Hansson E, Rönnbäck L. Neurons from substantia nigra increase the efficacy and potency of second messenger arising from striatal astroglia dopamine receptor. Glia. 1988;1:393–7.
Galloway A, et al. Dopamine triggers CTCF-dependent morphological and genomic remodeling of astrocytes. J Neurosci. 2018;38:4846–58.
Koppel I, et al. Dopamine cross-reacts with adrenoreceptors in cortical astrocytes to induce BDNF expression, CREB signaling and morphological transformation. Glia. 2018;66:206–16.
Oe Y, et al. Distinct temporal integration of noradrenaline signaling by astrocytic second messengers during vigilance. Nat Commun. 2020;11:1–15.
Pérez-Alvarez A, Araque A, Martín ED. Confocal microscopy for astrocyte in vivo imaging: recycle and reuse in microscopy. Front Cell Neurosci. 2013;7:51.
Yu X, et al. Reducing astrocyte calcium signaling in vivo alters striatal microcircuits and causes repetitive behavior. Neuron. 2018;99:1170–87. e9
Lines J, et al. Astrocytes modulate sensory-evoked neuronal network activity. Nat Commun. 2020;11:1–12.
Qin H, et al. Monitoring astrocytic Ca2+ activity in freely behaving mice. Front Cell Neurosci. 2020;14:410.
Ingiosi AM, et al. A role for astroglial calcium in mammalian sleep and sleep regulation. Curr Biol. 2020;30:4373–4383. e7
Vaarmann A, Gandhi S, Abramov AY. Dopamine induces Ca2+ signaling in astrocytes through reactive oxygen species generated by monoamine oxidase. J Biol Chem. 2010;285:25018–23.
Jennings A, et al. Dopamine elevates and lowers astroglial Ca(2+) through distinct pathways depending on local synaptic circuitry. Glia. 2017;65:447–59.
Volkow ND, Wise RA, Baler R. The dopamine motive system: implications for drug and food addiction. Nat Rev Neurosci. 2017;18:741–52.
Yu X, Nagai J, Khakh BS. Improved tools to study astrocytes. Nat Rev Neurosci. 2020;21:121–38.
Savtchouk I, Volterra A. Gliotransmission: beyond black-and-white. J Neurosci. 2018;38:14–25.
Fiacco TA, McCarthy KD. Multiple lines of evidence indicate that gliotransmission does not occur under physiological conditions. J Neurosci. 2018;38:3–13.
Halassa MM, Fellin T, Haydon PG. The tripartite synapse: roles for gliotransmission in health and disease. Trends Mol Med. 2007;13:54–63.
Trudeau LE. Neurotensin regulates intracellular calcium in ventral tegmental area astrocytes: evidence for the involvement of multiple receptors. Neuroscience. 2000;97:293–302.
Gould T, et al. GABA(B) receptor-mediated activation of astrocytes by gamma-hydroxybutyric acid. Philos Trans R Soc Lond B Biol Sci. 2014;369:20130607.
Araque A, et al. SNARE protein-dependent glutamate release from astrocytes. J Neurosci. 2000;20:666–73.
Gomez JA, et al. Ventral tegmental area astrocytes orchestrate avoidance and approach behavior. Nat Commun. 2019;10:1–13.
Molnár T, et al. Activation of astroglial calcium signaling by endogenous metabolites succinate and gamma-hydroxybutyrate in the nucleus accumbens. Front Neuroenergetics. 2011;3:7.
Molnár T, et al. Calcium signals in the nucleus accumbens: activation of astrocytes by ATP and succinate. BMC Neurosci. 2011;12:96.
D’Ascenzo M, et al. mGluR5 stimulates gliotransmission in the nucleus accumbens. Proc Natl Acad Sci USA. 2007;104:1995–2000.
Corkrum M, et al. Opioid-mediated astrocyte–neuron signaling in the nucleus accumbens. Cells. 2019;8:586.
Svingos AL, et al. Ultrastructural immunocytochemical localization of mu-opioid receptors in rat nucleus accumbens: extrasynaptic plasmalemmal distribution and association with Leu5-enkephalin. J Neurosci. 1996;16:4162–73.
Perea G, Araque A. Properties of synaptically evoked astrocyte calcium signal reveal synaptic information processing by astrocytes. J Neurosci. 2005;25:2192–203.
Fellin T, et al. Neuronal synchrony mediated by astrocytic glutamate through activation of extrasynaptic NMDA receptors. Neuron. 2004;43:729–43.
Dunwiddie TV, Diao L, Proctor WR. Adenine nucleotides undergo rapid, quantitative conversion to adenosine in the extracellular space in rat hippocampus. J Neurosci. 1997;17:7673–82.
Cunha RA, Sebastião AM, Ribeiro J. Inhibition by ATP of hippocampal synaptic transmission requires localized extracellular catabolism by ecto-nucleotidases into adenosine and channeling to adenosine A1 receptors. J Neurosci. 1998;18:1987–95.
Bergles DE, Jahr CE. Glial contribution to glutamate uptake at Schaffer collateral-commissural synapses in the hippocampus. J Neurosci. 1998;18:7709–16.
Bergles DE, Diamond JS, Jahr CE. Clearance of glutamate inside the synapse and beyond. Curr Opin Neurobiol. 1999;9:293–8.
Conti F, Weinberg RJ. Shaping excitation at glutamatergic synapses. Trends Neurosci. 1999;22:451–8.
Huang YH, Bergles DE. Glutamate transporters bring competition to the synapse. Curr Opin Neurobiol. 2004;14:346–52.
Marcaggi P, Attwell D. Role of glial amino acid transporters in synaptic transmission and brain energetics. Glia. 2004;47:217–25.
Otis TS, et al. Interactions between glutamate transporters and metabotropic glutamate receptors at excitatory synapses in the cerebellar cortex. Neurochem Int. 2004;45:537–44.
Tzingounis AV, Wadiche JI. Glutamate transporters: confining runaway excitation by shaping synaptic transmission. Nat Rev Neurosci. 2007;8:935–47.
Oliet SH, Piet R, Poulain DA. Control of glutamate clearance and synaptic efficacy by glial coverage of neurons. Science. 2001;292:923–6.
Danbolt NC. Glutamate uptake. Prog Neurobiol. 2001;65:1–105.
Pawlak J, et al. Regulation of glutamate transporter GLAST and GLT-1 expression in astrocytes by estrogen. Brain Res Mol Brain Res. 2005;138:1–7.
Autry AE, et al. Glucocorticoid regulation of GLT-1 glutamate transporter isoform expression in the rat hippocampus. Neuroendocrinology. 2006;83:371–9.
Zschocke J, et al. Differential promotion of glutamate transporter expression and function by glucocorticoids in astrocytes from various brain regions. J Biol Chem. 2005;280:34924–32.
Frizzo ME, et al. Extracellular adenosine triphosphate induces glutamate transporter-1 expression in hippocampus. Hippocampus. 2007;17:305–15.
Wu J, et al. Regulation of ethanol-sensitive EAAT2 expression through adenosine A1 receptor in astrocytes. Biochem Biophys Res Commun. 2011;406:47–52.
Roberts-Wolfe DJ, Kalivas PW. Glutamate transporter GLT-1 as a therapeutic target for substance use disorders. CNS Neurol Disord Drug Targets. 2015;14:745–56.
Kalivas PW, et al. Glutamate transmission in addiction. Neuropharmacology. 2009;56:169–73.
Kalivas PW. The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci. 2009;10:561–72.
Scofield M, et al. The nucleus accumbens: mechanisms of addiction across drug classes reflect the importance of glutamate homeostasis. Pharmacol Rev. 2016;68:816–71.
Scofield MD, Kalivas PW. Astrocytic dysfunction and addiction: consequences of impaired glutamate homeostasis. Neuroscientist. 2014;20:610–22.
Durkee CA, et al. Gi/o protein‐coupled receptors inhibit neurons but activate astrocytes and stimulate gliotransmission. Glia. 2019;67:1076–93.
Covelo A, Araque A. Neuronal activity determines distinct gliotransmitter release from a single astrocyte. Elife. 2018;7:e32237.
Haydon PG, et al. Astrocytic control of synaptic transmission and plasticity: a target for drugs of abuse? Neuropharmacology. 2009;56:83–90.
Bachtell RK, et al. Glial and neuroinflammatory targets for treating substance use disorders. Drug Alcohol Depend. 2017;180:156–70.
Kim R, et al. Astroglial correlates of neuropsychiatric disease: from astrocytopathy to astrogliosis. Prog Neuropsychopharmacol Biol Psychiatry. 2018;87:126–46.
Wang J, et al. Astrocytes in cocaine addiction and beyond. Mol Psychiatry. 2021; in press.
Bull C, et al. Rat nucleus accumbens core astrocytes modulate reward and the motivation to self-administer ethanol after abstinence. Neuropsychopharmacology. 2014;39:2835–45.
Nwachukwu KN, et al. Chemogenetic manipulation of astrocytic signaling in the basolateral amygdala reduces binge‐like alcohol consumption in male mice. J Neurosci Res. 2021; in press.
Scofield MD, et al. Gq-DREADD selectively initiates glial glutamate release and inhibits cue-induced cocaine seeking. Biol Psychiatry. 2015;78:441–51.
Siemsen BM, et al. Effects of methamphetamine self-administration and extinction on astrocyte structure and function in the nucleus accumbens core. Neuroscience. 2019;406:528–41.
Sarkisyan D, et al. Damaged reward areas in human alcoholics: neuronal proportion decline and astrocyte activation. Acta Neuropathologica. 2017;133:485–7.
Ramaker RC, et al. Post-mortem molecular profiling of three psychiatric disorders. Genome Med. 2017;9:1–12.
Navarrete M, et al. Astrocyte calcium signal and gliotransmission in human brain tissue. Cereb Cortex. 2013;23:1240–6.
Hearing M, et al. Opioid and psychostimulant plasticity: targeting overlap in nucleus accumbens glutamate signaling. Trends Pharm Sci. 2018;39:276–94.
Scofield MD, et al. The nucleus accumbens: mechanisms of addiction across drug classes reflect the importance of glutamate homeostasis. Pharm Rev. 2016;68:816–71.
Monai H, et al. Calcium imaging reveals glial involvement in transcranial direct current stimulation-induced plasticity in mouse brain. Nat Commun. 2016;7:11100.
Monai H, Hirase H. Astrocytes as a target of transcranial direct current stimulation (tDCS) to treat depression. Neurosci Res. 2018;126:15–21.
Mladinov M, et al. Astrocyte expression of D2-like dopamine receptors in the prefrontal cortex. Transl Neurosci. 2010;1:238–43.
Khan ZU, et al. An astroglia-linked dopamine D2-receptor action in prefrontal cortex. Proc Natl Acad Sci USA. 2001;98:1964–9.
Pelassa S, et al. A2A-D2 heteromers on striatal astrocytes: biochemical and biophysical evidence. Int J Mol Sci. 2019;20:2457.
Cervetto C, et al. A2A‐D2 receptor–receptor interaction modulates gliotransmitter release from striatal astrocyte processes. J Neurochemistry. 2017;140:268–79.
Cervetto C, et al. Homocysteine and A2A-D2 receptor-receptor interaction at striatal astrocyte processes. J Mol Neurosci. 2018;65:456–66.
Requardt RP, et al. The biphasic NAD (P) H fluorescence response of astrocytes to dopamine reflects the metabolic actions of oxidative phosphorylation and glycolysis. J Neurochemistry. 2010;115:483–92.
Liu J, et al. Activation of phosphatidylinositol-linked novel D 1 dopamine receptor contributes to the calcium mobilization in cultured rat prefrontal cortical astrocytes. Cell Mol Neurobiol. 2009;29:317–28.
Xin W, et al. Ventral midbrain astrocytes display unique physiological features and sensitivity to dopamine D2 receptor signaling. Neuropsychopharmacology. 2019;44:344–55.
Reuss B, Unsicker K. Atypical neuroleptic drugs downregulate dopamine sensitivity in rat cortical and striatal astrocytes. Mol Cell Neurosci. 2001;18:197–209.
Hösli L, et al. Action of dopamine and serotonin on the membrane potential of cultured astrocytes. Exp Brain Res. 1987;65:482–5.
Martin R, et al. Circuit-specific signaling in astrocyte-neuron networks in basal ganglia pathways. Science. 2015;349:730–4.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Corkrum, M., Araque, A. Astrocyte-neuron signaling in the mesolimbic dopamine system: the hidden stars of dopamine signaling. Neuropsychopharmacol. 46, 1864–1872 (2021). https://doi.org/10.1038/s41386-021-01090-7